SistemRNA™: Drug Repositioning & Re-purposing in vitro

SistemRNA™ applies a compound-centric approach identifying drug effects by associative changes in miRNA expression profiles and its analysis in context. The addition of SistemRNA™ to companies’ drug discovery toolbox can help them support strategic decision-making at key stages and maximise asset value. The miRNA expression profiles are used to characterise drugs on the basis of:

  • Positioning/repositioning of small molecule or biologic compound libraries
  • Identify biological activity and Mechanism of Action
  • Toxicology profile
  • On/Off-target effects